Hopwood Financial Services »

Iovance Biotherapeutics shares owned by Hopwood Financial Services

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Hopwood Financial Services from 13F filings

Historical chart of Hopwood Financial Services investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Hopwood Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Hopwood Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.3k 2.0k 2.17
2025-06-30 $3.4k 2.0k 1.72
2025-03-31 $6.7k 2.0k 3.33
2024-12-31 $15k 2.0k 7.40

More positions owned by Hopwood Financial Services

Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Exxon Mobil Corporation (XOM)
T Rowe Price Etf Price Blue Chip (TCHP)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard World Inf Tech Etf (VGT)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
T Rowe Price Etf Us Equity Resear (TSPA)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)

View all positions for Hopwood Financial Services

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics